Small -dose cyclophosphamide enhances chemotherapeutic effect of doxorubicin against mice hepatoma through inhibition of regulatory T cell

SHEN Shun-li,LIANG Li-jian,PENG Bao-gang,KUANG Ming,LAI Jia-ming,LI Dong-ming
DOI: https://doi.org/10.3969/j.issn.1674-7402.2009.02.004
2009-01-01
Abstract:Objective To investigate whether small-dose cyclophosphamide(CTX) can enhance chemotherapeutic effect of doxorubicin against mice hepatoma and its possible mechanisms. Methods C57BL/6J subcutaneous hepatoma model was established and when the tumor volume reached to 100~150 mm~3,mice were divided into groups.Ten mice were randomly divided into two group.2 mg CTX was injected i.p and 4 days later flowcytometry was used to examine the percentage of CD4~+,CD8~+ lymphocytes and CD4~+CD25high regulatory T cell(Treg).Another 32 mice were randomly divided into 4 groups;(1 )Control group;(2)CTX group;(3) Doxorubicin group(DOX); (4)CTX + DOX group.Mice were examined for tumor growth and survival.Results After application of low-dose CTX,the infiltration of CD4~+ and CD8~+ T lymphocytes in mice spleen increased from 17.62%,16.03%to 24.54%and 25.41%(P<0.05) respectively,while Treg decreased from 11.92% to 5.36%(P<0.05).There was no significant difference in tumor growth between the control and CTX groups(P>0.05).Tumor growth of DOX group,CTX+DOX group were significantly inhibited, especially CTX +DOX group(P<0.05).Survival analysis showed that there was no significant difference in survival between the control and CTX groups.Survival of DOX group was significantly improved(P=0.027).Compared with DOX group,survival time of CTX+DOX group was significantly increased(P = 0.018).Conclusion Low-dose CTX can inhibit Treg infiltration in spleen and enhance chemotherapeutic effect of doxorubicin against mice hepatoma.Immuno-chemotherapy might represent a promising treatment modality for hepatocellular carcinoma.
What problem does this paper attempt to address?